McCredie M, Macfarlane G J, Stewart J, Coates M
New South Wales Cancer Council, Cancer Epidemiology Research Unit, Australia.
Cancer Causes Control. 1996 May;7(3):337-44. doi: 10.1007/BF00052939.
Data from the New South Wales (NSW) (Australia) Central Cancer Registry for the period 1972-91 were examined to determine the risk of second primary cancers following an initial invasive cancer of the renal parenchyma (ICD-9 code 189.0), renal pelvis (code 189.1), or prostate (code 185). Eligible cases were restricted to those who had survived for at least two months after diagnosis of the first primary cancer. Expected numbers of cancers were obtained by assuming that subjects experienced the same cancer incidence as prevailed in the corresponding general population and applying gender-, age-, and calendar-specific rates to the appropriate person-years at risk. The relative risk (RR) of a second primary cancer was taken to be the ratio of observed to expected numbers of second cancers. Following prostatic cancer, there was an overall deficit of cancers at all sites combined (RR = 0.79, 95 percent confidence interval [CI] = 0.75-0.84), and no site had a significantly raised RR. Taking this into consideration, there appeared to be a reciprocal relationship of increased risk of prostatic cancer (RR = 1.7, CI = 1.2-2.3) following an initial cancer of the renal parenchyma and of renal parenchymal cancer (RR = 1.2, CI = 0.8-1.7) after cancer of the prostate. An increased risk of bladder cancer occurred following renal parenchymal (RR = 3.4, CI = 1.1-8.0, for women only) as well as after renal pelvic cancer (men: RR = 8.7, CI = 5.4-13; women: RR = 39, CI = 26-56). A tobacco-related pattern of excess risk was seen after renal pelvic cancer but not after cancer of the renal parenchyma. These data illustrate that an excess of second primary cancers may reflect shared etiologic factors or increased medical surveillance.
对来自澳大利亚新南威尔士州中央癌症登记处1972 - 1991年期间的数据进行了检查,以确定在首次发生肾实质浸润性癌(国际疾病分类第九版代码189.0)、肾盂癌(代码189.1)或前列腺癌(代码185)之后发生第二原发性癌症的风险。符合条件的病例仅限于那些在诊断出第一原发性癌症后存活至少两个月的患者。通过假设受试者经历与相应普通人群相同的癌症发病率,并将性别、年龄和日历特定的发病率应用于适当的风险人年数,得出癌症的预期数量。第二原发性癌症的相对风险(RR)被视为观察到的第二癌症数量与预期数量的比值。前列腺癌之后,所有部位的癌症总体上存在不足(RR = 0.79,95%置信区间[CI] = 0.75 - 0.84),且没有一个部位的RR显著升高。考虑到这一点,在首次发生肾实质癌之后,前列腺癌风险增加(RR = 1.7,CI = 1.2 - 2.3),而在前列腺癌之后,肾实质癌风险增加(RR = 1.2,CI = 0.8 - 1.7),似乎存在一种相互关系。肾实质癌(仅女性:RR = 3.4,CI = 1.1 - 8.0)以及肾盂癌之后(男性:RR = 8.7,CI = 5.4 - 13;女性:RR = 39,CI = 26 - 56),膀胱癌风险增加。肾盂癌之后出现了与烟草相关的风险增加模式,但肾实质癌之后未出现。这些数据表明,第二原发性癌症的过多可能反映了共同的病因因素或增加的医学监测。